Christian D. DeMoya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Christian D. DeMoya has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Mark W. Grinstaff
Boston University
7 shared publications - Brian D. Snyder
Boston Children's Hospital Boston Massachusetts USA
4 shared publications Anisha Joenathan
Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center
2 shared publications- Dev R. Mehrotra
College of Engineering, Boston University, Boston, MA
2 shared publications - Kaitlynn A. Sockett
Department of Chemistry, Boston University, Room 519, 590 Commonwealth Ave, Boston, MA 02215, USA
2 shared publications - Madeline Loffredo
Boston University
2 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (6) , 1530-1543
Clickable polyamidosaccharides: accessing bottlebrush inspired hyaluronic acid glycopolymers for CD44 targeting of breast cancer cells
Polyamidosaccharides armed with hyaluronic acid disaccharide branches bind the transmembrane glycoprotein cluster of differentiation-44 (CD44), a highly expressed surface receptor that plays a critical role in tumor growth, invasion, and metastasis.
- 17 February 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (6) , 1530-1543
Open AccessClickable polyamidosaccharides: accessing bottlebrush inspired hyaluronic acid glycopolymers for CD44 targeting of breast cancer cells
Polyamidosaccharides armed with hyaluronic acid disaccharide branches bind the transmembrane glycoprotein cluster of differentiation-44 (CD44), a highly expressed surface receptor that plays a critical role in tumor growth, invasion, and metastasis.
- 15 December 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 212, 202-215
A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage
- 15 December 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 212, 202-215
A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage
- Open Access
- 22 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Clickable polyamidosaccharides
Hyaluronic acid (HA) binds the transmembrane glycoprotein cluster of differentiation-44 (CD44), a highly expressed surface receptor that plays a critical role in tumor growth, invasion, and metastasis. Approaches to target CD44 utilize biologically sourced HA which inherently suffers from molecular weight (Mw) heterogeneity and biological contaminants. Fully synthetic approaches to HA are attractive and circumvent these biological contaminants; however, readily accessing oligomers of six monosaccharides or more, as is required for CD44 binding, is challenging. To this end, we report the synthesis of carbohydrate-based glycopolymers functionalized with HA disaccharide pendant chains. These well-defined and chemoselective polymers consist of glucose monomers linked via -1,2 amide bonds, termed polyamidosaccharides, functionalized with branched HA disaccharide moieties interspersed throughout via a strain-promoted azide-alkyne cycloaddition. Among these homopolymers and copolymers, two of the polymers bearing the highest HA disaccharide conjugation bind CD44 with nanomolar affinity. Assays using a rhodamine-labeled polymer reveal a positive relationship between cellular internalization and CD44 expression levels in breast cancer cells. Conjugation of paclitaxel to the polymer results in enhanced paclitaxel efficacy in CD44-expressing cancer cells compared to free paclitaxel.
- 22 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessClickable polyamidosaccharides
Hyaluronic acid (HA) binds the transmembrane glycoprotein cluster of differentiation-44 (CD44), a highly expressed surface receptor that plays a critical role in tumor growth, invasion, and metastasis. Approaches to target CD44 utilize biologically sourced HA which inherently suffers from molecular weight (Mw) heterogeneity and biological contaminants. Fully synthetic approaches to HA are attractive and circumvent these biological contaminants; however, readily accessing oligomers of six monosaccharides or more, as is required for CD44 binding, is challenging. To this end, we report the synthesis of carbohydrate-based glycopolymers functionalized with HA disaccharide pendant chains. These well-defined and chemoselective polymers consist of glucose monomers linked via -1,2 amide bonds, termed polyamidosaccharides, functionalized with branched HA disaccharide moieties interspersed throughout via a strain-promoted azide-alkyne cycloaddition. Among these homopolymers and copolymers, two of the polymers bearing the highest HA disaccharide conjugation bind CD44 with nanomolar affinity. Assays using a rhodamine-labeled polymer reveal a positive relationship between cellular internalization and CD44 expression levels in breast cancer cells. Conjugation of paclitaxel to the polymer results in enhanced paclitaxel efficacy in CD44-expressing cancer cells compared to free paclitaxel.
- Open Access
A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage
Cartilage extracellular matrix (ECM) comprises a type-II collagen fibril network that affords structure and tensile strength, complemented by a negatively charged, sulfated glycosaminoglycan (GAG) matrix that retains interstitial water. These components act synergistically, bestowing the rheological and tribological material properties essential to cartilage function. At the onset of osteoarthritis, a disease characterized by cartilage degeneration, GAGs diminish from the ECM reducing interstitial fluid load support ( IFLS ) and transferring load to the collagen fibril network, which subsequently breaks down, culminating in increased hydraulic permeability, and decreased cartilage stiffness. We restore the material properties of damaged cartilage critical to diarthrodial joint function by forming an interpenetrating polymer network (IPN) with the native collagen using a synthetic, hydrophilic, and biocompatible GAG-mimetic polymer. Upon visible light activation, the monomer, 3-sulfopropylmethacrylate (SPM), and the crosslinker, polyethylene glycol diacrylate (PEGDA), form a sulfonated and anionic IPN that entangles and fills the existing porous degraded collagen matrix. Mechanistically, the highly sulfated, anionic SPM IPN retards water transport, reestablishes collagen fibril network integrity, and restores tissue IFLS , thereby returning the stiffness and viscoelastic properties of degraded cartilage to healthy levels. Additionally, the SPM IPN protects cartilage from further degradation by reducing the infiltration of inflammatory cytokines that upregulate catabolic matrix metalloproteinases and downregulate GAG production. Statement of significance: Amelioration of OA requires a comprehensive approach: neutralize or impede catabolic enzymes that degrade cartilage and reconstitute damaged cartilage by augmenting tissue ECM constituents. Currently, there are no clinical treatments that restore the viscoelastic material properties of hyaline cartilage tissue critical to its mechanical function and impart chondroprotection after OA induction. This work suggests that reconstituting GAG-depleted cartilage using a synthetic sulfonated interpenetrating polymer to reestablish IFLS that can be instilled into the joint and polymerized with white light during conventional arthroscopy represents a novel, minimally invasive, clinical treatment for early OA.
Open AccessA sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage
Cartilage extracellular matrix (ECM) comprises a type-II collagen fibril network that affords structure and tensile strength, complemented by a negatively charged, sulfated glycosaminoglycan (GAG) matrix that retains interstitial water. These components act synergistically, bestowing the rheological and tribological material properties essential to cartilage function. At the onset of osteoarthritis, a disease characterized by cartilage degeneration, GAGs diminish from the ECM reducing interstitial fluid load support ( IFLS ) and transferring load to the collagen fibril network, which subsequently breaks down, culminating in increased hydraulic permeability, and decreased cartilage stiffness. We restore the material properties of damaged cartilage critical to diarthrodial joint function by forming an interpenetrating polymer network (IPN) with the native collagen using a synthetic, hydrophilic, and biocompatible GAG-mimetic polymer. Upon visible light activation, the monomer, 3-sulfopropylmethacrylate (SPM), and the crosslinker, polyethylene glycol diacrylate (PEGDA), form a sulfonated and anionic IPN that entangles and fills the existing porous degraded collagen matrix. Mechanistically, the highly sulfated, anionic SPM IPN retards water transport, reestablishes collagen fibril network integrity, and restores tissue IFLS , thereby returning the stiffness and viscoelastic properties of degraded cartilage to healthy levels. Additionally, the SPM IPN protects cartilage from further degradation by reducing the infiltration of inflammatory cytokines that upregulate catabolic matrix metalloproteinases and downregulate GAG production. Statement of significance: Amelioration of OA requires a comprehensive approach: neutralize or impede catabolic enzymes that degrade cartilage and reconstitute damaged cartilage by augmenting tissue ECM constituents. Currently, there are no clinical treatments that restore the viscoelastic material properties of hyaline cartilage tissue critical to its mechanical function and impart chondroprotection after OA induction. This work suggests that reconstituting GAG-depleted cartilage using a synthetic sulfonated interpenetrating polymer to reestablish IFLS that can be instilled into the joint and polymerized with white light during conventional arthroscopy represents a novel, minimally invasive, clinical treatment for early OA.
- 3 April 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (15) , 22352-22361
Nanoparticle Lubricant and Imaging Agent: Preventing and Assessing Cartilage Tissue Damage
Introducing additives to industrial lubricants reduces friction and wear between articulating metal surfaces by mechanistically impeding interfacial adhesion, heat dissipation, and abrasion. With this inspiration, we report the synthesis and use of tantalum oxide (Ta2O5) nanoparticles as a nanolubricant and tribosupplement (i.e., tribology-augmenting agent) for articular cartilage. Further, as tantalum oxide absorbs X-rays, the nanolubricant is also a contrast-agent for computed tomography (CT). These dual purpose nanoparticles, decorated with a short poly (ethylene glycol) and cationic trimethylammonium silane coating, suspend in aqueous fluid to form a CT active nanolubricant. In an ex vivo cartilage-on-cartilage model, the nanolubricant outperforms the clinical standard, Synvisc-One, as a viscosupplement during high load, low velocity sliding associated with low Hersey numbers and high static friction. Differential diffusion of the nanolubricants into healthy and degraded cartilage demonstrates the diagnostic capability of the nanolubricant to also distinguish disease state by μCT.
- 3 April 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (15) , 22352-22361
Nanoparticle Lubricant and Imaging Agent: Preventing and Assessing Cartilage Tissue Damage
Introducing additives to industrial lubricants reduces friction and wear between articulating metal surfaces by mechanistically impeding interfacial adhesion, heat dissipation, and abrasion. With this inspiration, we report the synthesis and use of tantalum oxide (Ta2O5) nanoparticles as a nanolubricant and tribosupplement (i.e., tribology-augmenting agent) for articular cartilage. Further, as tantalum oxide absorbs X-rays, the nanolubricant is also a contrast-agent for computed tomography (CT). These dual purpose nanoparticles, decorated with a short poly (ethylene glycol) and cationic trimethylammonium silane coating, suspend in aqueous fluid to form a CT active nanolubricant. In an ex vivo cartilage-on-cartilage model, the nanolubricant outperforms the clinical standard, Synvisc-One, as a viscosupplement during high load, low velocity sliding associated with low Hersey numbers and high static friction. Differential diffusion of the nanolubricants into healthy and degraded cartilage demonstrates the diagnostic capability of the nanolubricant to also distinguish disease state by μCT.
- Top Cited Papers
- 10 June 2024
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 20 (7) , 432-451
Advances in viscosupplementation and tribosupplementation for early-stage osteoarthritis therapy
Joint kinematic instability, arising from congenital or acquired musculoskeletal pathoanatomy or from imbalances in anabolism and catabolism induced by pathophysiological factors, leads to deterioration of the composition, structure and function of cartilage and, ultimately, progression to osteoarthritis (OA). Alongside articular cartilage degeneration, synovial fluid lubricity decreases in OA owing to a reduction in the concentration and molecular weight of hyaluronic acid and surface-active mucinous glycoproteins that form a lubricating film over the articulating joint surfaces. Minimizing friction between articulating joint surfaces by lubrication is fundamental for decreasing hyaline cartilage wear and for maintaining the function of synovial joints. Augmentation with highly viscous supplements (that is, viscosupplementation) offers one approach to re-establishing the rheological and tribological properties of synovial fluid in OA. However, this approach has varied clinical outcomes owing to limited intra-articular residence time and ineffective mechanisms of chondroprotection. This Review discusses normal hyaline cartilage function and lubrication and examines the advantages and disadvantages of various strategies for restoring normal joint lubrication. These strategies include contemporary viscosupplements that contain antioxidants, anti-inflammatory drugs or platelet-rich plasma and new synthetic synovial fluid additives and cartilage matrix enhancers. Advanced biomimetic tribosupplements offer promise for mitigating cartilage wear, restoring joint function and, ultimately, improving patient care.
- 10 June 2024
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 20 (7) , 432-451
Top Cited PapersAdvances in viscosupplementation and tribosupplementation for early-stage osteoarthritis therapy
Joint kinematic instability, arising from congenital or acquired musculoskeletal pathoanatomy or from imbalances in anabolism and catabolism induced by pathophysiological factors, leads to deterioration of the composition, structure and function of cartilage and, ultimately, progression to osteoarthritis (OA). Alongside articular cartilage degeneration, synovial fluid lubricity decreases in OA owing to a reduction in the concentration and molecular weight of hyaluronic acid and surface-active mucinous glycoproteins that form a lubricating film over the articulating joint surfaces. Minimizing friction between articulating joint surfaces by lubrication is fundamental for decreasing hyaline cartilage wear and for maintaining the function of synovial joints. Augmentation with highly viscous supplements (that is, viscosupplementation) offers one approach to re-establishing the rheological and tribological properties of synovial fluid in OA. However, this approach has varied clinical outcomes owing to limited intra-articular residence time and ineffective mechanisms of chondroprotection. This Review discusses normal hyaline cartilage function and lubrication and examines the advantages and disadvantages of various strategies for restoring normal joint lubrication. These strategies include contemporary viscosupplements that contain antioxidants, anti-inflammatory drugs or platelet-rich plasma and new synthetic synovial fluid additives and cartilage matrix enhancers. Advanced biomimetic tribosupplements offer promise for mitigating cartilage wear, restoring joint function and, ultimately, improving patient care.
- 12 October 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (22) , 7339-7345
A polymer network architecture provides superior cushioning and lubrication of soft tissue compared to a linear architecture
We report the relationships between linear vs. network polymer architecture and biomechanical outcomes including lubrication and cushioning when the polymers are applied to the surface of articulating knee cartilage.
- 12 October 2023
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (22) , 7339-7345
A polymer network architecture provides superior cushioning and lubrication of soft tissue compared to a linear architecture
We report the relationships between linear vs. network polymer architecture and biomechanical outcomes including lubrication and cushioning when the polymers are applied to the surface of articulating knee cartilage.
- 19 February 2020
- Published by Elsevier in Journal of Immunology and Regenerative Medicine
- Vol. 8
Single cell sequencing analysis of lizard phagocytic cell populations and their role in tail regeneration
- 19 February 2020
- Published by Elsevier in Journal of Immunology and Regenerative Medicine
- Vol. 8
Single cell sequencing analysis of lizard phagocytic cell populations and their role in tail regeneration